2026-526215-10-00招募中1 期
A Study to Evaluate the Safety, Tolerability, and Activity of a Novel Oral Anticancer Drug (FLC‑436) in Patients With Refractory or Relapsed Solid Malignancies
Fileclo Sp. z o.o.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年8月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical trial information point
Scientific
Fileclo Sp. z o.o.
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389Obesity / Right heart failure (healthy participants)2024-514853-31-00Corteria Pharmaceuticals80
已完成
1 期
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Zosurabalpin following Intravenous Administration in Healthy ParticipantsThere is no medical condition being investigated. This is a safety and pharmacokinetic study to be performed in healthy participants.2023-505411-20-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG30
招募中
1 期
A study investigating the safety, tolerability, metabolism, and elimination of INE963, a new compound in the treatment of malaria.Malaria2024-516911-26-00Novartis Pharma AG94
已完成
1 期
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants with Early Idiopathic Parkinson’s DiseaseEarly Idiopathic Parkinson’s Disease (PD)2023-504412-14-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG20
招募中
1 期
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell MalignanciesB-cell non-Hodgkin lymphoma (NHL)2024-514938-20-00Regeneron Pharmaceuticals Inc.65